RAVI KALYANARAMAN, Scientific Director - Forensics and Innovative Technologies (FIT), Bristol-Myers Squibb

Ravi Kalyanaraman, PhD is the Director of the Forensics and Innovative Technologies (FIT) group within Global Quality Analytical Science and Technology at Bristol‑Myers Squibb (BMS) Company. He received his PhD from the University of Idaho in 1995 and did his post-doctoral work at the University of Puerto Rico. He has been with BMS since 2002 and his work has focused on leading and developing new and novel analytical techniques to detect pharmaceutical counterfeits, and to support particulate and foreign matter characterization in the manufacturing process (bio, pharma, and cell therapy).

His interests are mainly in using vibrational spectroscopic techniques, such as Raman, mid- and near-infrared (NIR) and hyperspectral imaging for pharmaceutical counterfeit detection. His group extensively uses microscopy (IR, Raman and SEM) and energy dispersive spectroscopy (EDS) for elemental analysis for particulate and foreign matter investigations. He leads a team in global quality organization that is involved in the analysis of products received from patient complaints and from corporate security groups.